Over-the-counter orlistat. A weight loss "Alli" or adversary on the horizon.
Anderson
Theresa
T
Kaiser Permanente, Salem, OR, USA.
D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D017277:Drug Approval; D004347:Drug Interactions; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D008286:Malabsorption Syndromes / Q000139:chemically induced; D004366:Nonprescription Drugs / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D009765:Obesity / Q000453:epidemiology / Q000517:prevention & control; D000077403:Orlistat; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012449:Safety; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D019440:Anti-Obesity Agents; D007783:Lactones; D004366:Nonprescription Drugs; D000077403:Orlistat